Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wahlestedt

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Regulatory Peptides|February 1, 1986
Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptidesC Wahlestedt, N Yanaihara, R Håkanson
Journal of Clinical Pharmacy and Therapeutics|June 26, 2002
The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean populationB Ding, L Bertilsson, C Wahlestedt
Advanced Drug Delivery Reviews|May 31, 2015
Basic biology and therapeutic implications of lncRNAO Khorkova, J Hsiao, C Wahlestedt
European Journal of Pharmacology|November 22, 1988
Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptorsM Heilig, C Wahlestedt, E Widerlöv
Acta Physiologica Scandinavica|April 1, 1987
Effects of neuropeptide Y (NPY) on isolated guinea-pig heartC Wahlestedt, B Wohlfart, R Håkanson
European Journal of Pharmacology|December 10, 1991
Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor bindingM Heilig, L Edvinsson, C Wahlestedt
European Journal of Pharmacology|November 27, 1984
Pupillary constriction by bradykinin and capsaicin: mode of actionC Wahlestedt, G Bynke, R Håkanson
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1991
Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstemL Grundemar, C Wahlestedt, D J Reis
Life Sciences|January 1, 1992
Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YYC Wahlestedt, S Regunathan, D J Reis
Biochemical Pharmacology|March 17, 1992
Specific binding of inositol hexakisphosphate (phytic acid) to adrenal chromaffin cell membranes and effects on calcium-dependent catecholamine releaseS Regunathan, D J Reis, C Wahlestedt
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Regulatory Peptides|February 1, 1986
Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptidesC Wahlestedt, N Yanaihara, R Håkanson
Journal of Clinical Pharmacy and Therapeutics|June 26, 2002
The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean populationB Ding, L Bertilsson, C Wahlestedt
Advanced Drug Delivery Reviews|May 31, 2015
Basic biology and therapeutic implications of lncRNAO Khorkova, J Hsiao, C Wahlestedt
European Journal of Pharmacology|November 22, 1988
Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptorsM Heilig, C Wahlestedt, E Widerlöv
Acta Physiologica Scandinavica|April 1, 1987
Effects of neuropeptide Y (NPY) on isolated guinea-pig heartC Wahlestedt, B Wohlfart, R Håkanson
European Journal of Pharmacology|December 10, 1991
Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor bindingM Heilig, L Edvinsson, C Wahlestedt
European Journal of Pharmacology|November 27, 1984
Pupillary constriction by bradykinin and capsaicin: mode of actionC Wahlestedt, G Bynke, R Håkanson
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1991
Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstemL Grundemar, C Wahlestedt, D J Reis
Life Sciences|January 1, 1992
Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YYC Wahlestedt, S Regunathan, D J Reis
Biochemical Pharmacology|March 17, 1992
Specific binding of inositol hexakisphosphate (phytic acid) to adrenal chromaffin cell membranes and effects on calcium-dependent catecholamine releaseS Regunathan, D J Reis, C Wahlestedt
Pageof 12